使用基于蛋白质和的疗法来管理和预防致病病毒
Esmail M El-Fakharany1, Hamada El-Gendi2, Ahmed K Saleh3
1Protein Research Department, Genetic Engineering and Biotechnology Research Institute GEBRI, City of Scientific Research and Technological Applications (SRTA city), New Borg El-Arab, Alexandria 21934, Egypt; Pharmaceutical and Fermentation Industries Development Centre (PFIDC), City of Scientific Research and Technological Applications (SRTA-City), New Borg Al-Arab, Alexandria, Egypt.
International journal of biological macromolecules
|May 10, 2024
概括
治疗性蛋白质是重要的药物,预计到2030年将达到6530亿美元. 蛋白质工程策略提高了它们治疗疾病的有效性和稳定性.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 重组蛋白质的生产和应用.
- 用于治疗开发的蛋白质工程.
背景情况:
- 治疗性蛋白质占制药的重要部分,其市场价值在2023年为38703亿美元,预计到2030年将达到65335亿美元.
- 关键的治疗蛋白质包括生长激素,胰岛素和干扰素 (IFN α, γ, β),对于治疗代谢障碍,瘤和病毒感染至关重要.
- 重组DNA技术使得使用各种表达系统 (核细胞和真核细胞) 大规模生产治疗性蛋白质成为可能.
研究的目的:
- 提供对治疗性蛋白质研究和开发的全面概述.
- 突出基于蛋白质的疗法的市场增长和临床意义.
- 讨论治疗蛋白质优化的挑战和先进的蛋白质工程策略.
主要方法:
- 对治疗性蛋白质生产和应用的现有文献的审查.
- 对治疗性蛋白质市场趋势和经济预测的分析.
- 探索蛋白质工程技术 (PEGylation,Fc融合等) 的研究. 克服生产和应用的局限性.
主要成果:
- 治疗性蛋白质是制药行业快速增长的部门.
- 蛋白质生产的局限性包括免疫性,稳定性和降解.
- 蛋白质工程显著改善了准,纯度,产量,功能和循环半衰期.
结论:
- 先进的蛋白质工程对于克服治疗性蛋白质开发当前的局限性至关重要.
- 对治疗性蛋白质的持续研究和洞察力将推动其成功的临床实施.
- 基于蛋白质的疗法为广泛的疾病提供了有前途的解决方案.
相关概念视频
Antimicrobial Proteins
982
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
982
Immune Response Against Viral Pathogens
776
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
776
Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K


